/PXYN

PXYN Stock - Praxsyn Corporation

Q: What is the analyst price target for PXYN?

Analyst price target information is not currently available for PXYN.

Q: What is PXYN's market cap?

Market capitalization information is not currently available for PXYN.

Healthcare|Medical - Pharmaceuticals|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PXYN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2012

FY2013

FY2014

FY2017

FY2018

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.63

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2018	FY2017	FY2014	FY2013	FY2012
Revenue	$81,378	$819,091	$66.60M	$6.99M	N/A
Gross Profit	$23,913	$385,855	$63.01M	$6.29M	N/A
Gross Margin	29.4%	47.1%	94.6%	90.1%	N/A
Operating Income	$-196,000	$-2,714,000	$26.07M	$3.20M	$-2,723,000
Net Income	$-566,000	$-3,496,000	$-12,354,000	$230,061	$-1,219,000
Net Margin	-695.5%	-426.8%	-18.5%	3.3%	N/A
EPS	$-0.00	$-0.00	$-0.05	$0.00	$-0.02

Company Overview

Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers' compensation system, as well as preferred provider contracts. The company was formerly known as The PAWS Pet Company, Inc. and changed its name to Praxsyn Corporation in March 2014. Praxsyn Corporation was founded in 2005 and is headquartered in Las Vegas, Nevada.

Visit Website

Earnings History & Surprises

PXYN

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$N/A

EPS Surprise History

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2019	Mar 5, 2019	—	—	—	—

Frequently Asked Questions about PXYN

What is PXYN's current stock price?

Praxsyn Corporation (PXYN) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for PXYN?

No analyst price targets are currently available for this stock.

What sector is Praxsyn Corporation in?

Praxsyn Corporation operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.

What is PXYN's market cap?

Praxsyn Corporation has a market capitalization of $0.00 billion, making it a small-cap company.

Does PXYN pay dividends?

No, Praxsyn Corporation does not currently pay a dividend to shareholders.